Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting on Wegovy is one of the more distressing side effects people report, and it is more common in the first few weeks or after a dose increase than at any other point in treatment. For most people it settles; for some it signals that a conversation with their prescriber is overdue. The NHS semaglutide patient information page lists vomiting as a known, common side effect of semaglutide — so if this is happening to you, you are not having an unusual reaction. What matters now is understanding why it is happening, what you can do about it, and how to recognise the small number of signs that need prompt medical attention. These are prescription-only medicines; a prescriber, not a web page, is the right person to review your individual situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing the rate at which your stomach empties. That is useful for appetite control, but it also means your digestive system is adjusting to a fundamentally different rhythm. Food sits in the stomach longer, gastric pressure builds, and nausea or vomiting can follow, particularly if you eat too quickly, in larger portions than before, or while lying down soon afterwards.
The licensed dosing schedule starts low for exactly this reason. Each step up in dose reintroduces that adjustment period, which is why vomiting often returns briefly after moving to a higher pen even if things had settled. Most people find the intensity decreases over two to four weeks as the gut adapts. That pattern is not a guarantee, but it is the norm reflected in the trial data behind the NICE appraisal of Wegovy.
A few practical things tend to make a real difference: smaller meals, eating slowly, avoiding fatty or very spicy food in the first weeks, and staying upright for at least an hour after eating. Some people find keeping a Wegovy pen in the fridge door and injecting on a consistent evening routine (rather than a variable time) helps them track how they feel relative to each dose. None of this replaces prescriber advice, but it is the kind of detail worth raising in your next clinical review. If you want a closer look at what vomiting on Wegovy typically involves and how it tends to progress, that is worth reading before your next review. For a broader picture of what Wegovy side effects look like across treatment, the full side-effect guide covers the wider range.
This is the real question most people face after a few unpleasant episodes: is this something to manage through, or a signal to act on? The answer depends on a few factors, and getting them right is exactly what a prescriber is for.
Mild to moderate vomiting that is improving over two to three weeks, does not prevent you keeping fluids down, and is not affecting your ability to function is generally considered part of the adjustment. If vomiting is severe enough that you cannot keep water down for more than a few hours, dehydration becomes a clinical concern, not a minor inconvenience. Reduced urine output, dizziness when you stand, and a dry mouth are early signs. At that point, rest and ginger tea are not the answer.
Some people find that the dose they have moved to is too large a jump for their system, and a temporary step back or a slower titration brings things under control. That is a legitimate clinical decision, not a failure. Others find a simple tweak to injection timing or meal size resolves the issue. If you are finding that Wegovy is making you feel sick in a way that feels more persistent or disruptive than typical adjustment, that guide helps you work out whether what you are experiencing is within the expected range or something to escalate. You can read about how vomiting specifically after an injection tends to present differently from general nausea, which helps you describe your experience more precisely.
If you are finding that tiredness is piling on top of the nausea, our guide to Wegovy and fatigue explains how the two side effects are often linked and how to approach both at once.
Most vomiting on Wegovy does not require an emergency trip anywhere. Some does. Know the difference.
Get urgent medical help if you experience severe, persistent stomach pain that radiates towards your back, with or without vomiting. This is a recognised symptom pattern of acute pancreatitis, which the MHRA's Drug Safety Update of January 2026 specifically called out as a rare but serious risk with GLP-1 medicines. Do not wait to see if it passes.
Also seek prompt help for: vomiting that continues for more than 24 hours without improvement; signs of dehydration (dark urine, dizziness, confusion, rapid heartbeat); any signs of a serious allergic reaction such as swelling of the face or throat, or difficulty breathing; and right-sided abdominal pain under the ribs, which can indicate a gallbladder problem, another recognised association with rapid weight loss and GLP-1 treatment.
For milder ongoing nausea and vomiting that does not involve any of the above, the right route is your prescriber. At nume, a real clinician reviews every message that comes through aftercare, not a chatbot. If you are already a patient and something is not right, reach our team directly. If you are still considering treatment and want to understand suitability before starting, our prescribers discuss exactly this kind of question as part of the free consultation, including your personal risk profile for GI side effects. You can also read more about how Wegovy works as a licensed weight-management treatment in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.